Rapid Micro Biosystems (RMB) creates, sells, validates and services innovative products for fast, accurate, and efficient detection of microbial contamination in the manufacture of pharmaceuticals, biologics, biotechnology products, medical devices, and personal care products. The company?s Growth Direct??the first and only growth-based system to automate rapid compendial QC Micro testing?ensures data integrity, compliance, and operational efficiencies driven by rapid methods and automation. RMB is dedicated to providing groundbreaking technology and products to support companies in their journey to achieve greater reliability, efficiency, and better predictability, ultimately providing higher quality products for improved patient outcomes.
51 to 200 Employees
TypeCompany - Private
Revenue$25 to $50 million (USD)
IndustryBiotech & Pharmaceuticals
CompetitorsUnknown
Founded2006